KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $2.0 million.

  • Staar Surgical's Depreciation & Amortization (CF) rose 1383.04% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 4763.77%. This contributed to the annual value of $6.9 million for FY2024, which is 3482.68% up from last year.
  • Latest data reveals that Staar Surgical reported Depreciation & Amortization (CF) of $2.0 million as of Q3 2025, which was up 1383.04% from $2.0 million recorded in Q2 2025.
  • Staar Surgical's 5-year Depreciation & Amortization (CF) high stood at $2.4 million for Q4 2024, and its period low was $207000.0 during Q1 2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $1.3 million, with a median of $1.3 million in 2023.
  • Per our database at Business Quant, Staar Surgical's Depreciation & Amortization (CF) surged by 35265.7% in 2021 and then tumbled by 86.96% in 2023.
  • Quarter analysis of 5 years shows Staar Surgical's Depreciation & Amortization (CF) stood at $937000.0 in 2021, then skyrocketed by 47.28% to $1.4 million in 2022, then dropped by 0.87% to $1.4 million in 2023, then surged by 73.61% to $2.4 million in 2024, then decreased by 15.79% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.0 million for Q2 2025, and $2.3 million during Q1 2025.